(Total Views: 642)
Posted On: 08/20/2020 4:54:04 AM
Post# of 145875
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
After Several Months of Providing Requested Information About Manufacturing and Safety of Leronlimab, U.K.’s MHRA Accepts CytoDyn’s Request to Enroll in its Current Phase 3 Trial for COVID-19 Patients with Severe-to-Critical Symptoms
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)